Therefore, malignancy driver functions attributed in our work to p32 in colorectal cancer cells could be explained at least partly by its ability to significantly modify the transcription levels of HAS-2 and PDCD4 genes, and to its ability to activate the PI3K/Akt/mTOR signaling pathway. This evidence concerns the gene HAS2 and colorectal cancer.